or Try an Advanced Search...

    Technical Analysis for JUNS - Jupiter Neurosciences, Inc.

    Grade Last Price % Change Price Change
    D 5.96 -28.37% -2.36
    JUNS closed down 28.37 percent on Tuesday, January 14, 2025, on 1.87 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong N/A N/A Down
    Historical JUNS trend table...
    Date Alert Name Type % Chg
    Hot IPO Pullback Bullish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish -28.37%
    Volume Surge Other -28.37%
    Outside Day Range Expansion -28.37%
    Wide Bands Range Expansion -28.37%
    Older End-of-Day Signals for JUNS ...

       Recent Intraday Alerts

    Alert Time
    Down 1 ATR about 5 hours ago
    Fell Below Lower Bollinger Band about 9 hours ago
    3x Volume Pace about 10 hours ago
    Fell Below Previous Day's Low about 10 hours ago
    Down 10% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    JUNS Chart by TradingView

    Profile

    • Earnings date: Unknown
    Jupiter Neurosciences, Inc. is a clinical stage research and development pharmaceutical company. Its therapeutic candidate, JOTROL is applicable to many central nervous system diseases, including Alzheimer’s disease and traumatic brain injury. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in June 2015 and is headquartered in Jupiter, FL.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Central Nervous System Disease Traumatic Brain Injury Alzheimer’s Disease

    Is JUNS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jan 13 Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials
    Dec 4 Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering
    Dec 3 Jupiter Neurosciences stock rallies 37% following $11M IPO
    Dec 3 Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq
    See more JUNS news...

    Comments

    Indicators

    Indicator Value
    52 Week High 19.51
    52 Week Low 3.86
    Average Volume 502,637
    200-Day Moving Average 0.00
    50-Day Moving Average 0.00
    20-Day Moving Average 9.99
    10-Day Moving Average 8.89
    Average True Range 2.25
    RSI (14) 40.48
    ADX 55.98
    +DI 32.69
    -DI 16.85
    Chandelier Exit (Long, 3 ATRs) 12.75
    Chandelier Exit (Short, 3 ATRs) 12.47
    Upper Bollinger Bands 13.03
    Lower Bollinger Band 6.95
    Percent B (%b) -0.16
    BandWidth 60.81
    MACD Line -0.62
    MACD Signal Line -0.18
    MACD Histogram -0.4422
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.68
    Resistance 3 (R3) 10.01 9.10 9.06
    Resistance 2 (R2) 9.10 8.15 8.93 8.85
    Resistance 1 (R1) 7.53 7.57 7.08 7.20 8.65
    Pivot Point 6.62 6.62 6.39 6.46 6.62
    Support 1 (S1) 5.05 5.67 4.60 4.72 3.27
    Support 2 (S2) 4.14 5.09 3.98 3.07
    Support 3 (S3) 2.57 4.14 2.86
    Support 4 (S4) 2.24